Skip to main content

Neuroone Medical Technologies Corp

NMTC
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
SEC CIK
0001500198

In the last 90 days, Neuroone Medical Technologies Corp insiders filed 1 open-market purchase and 0 sales; 26 institutions reported holding it in 13F filings for Q2 2026, worth $6.21M in total; no superinvestor holds it.

Q4 2021 vs. Q3 2021

How the institutions holding Neuroone Medical Technologies Corp changed between Q3 2021 and Q4 2021.

All holders in Q4 2021All holders in Q3 2021

13F holders of NMTC: Q3 2021 compared with Q4 2021
MeasureQ3 2021Q4 2021Change
Holders917+8
Shares1.25M3.36M+2.11M (+168.7%)
Value$4.94M$6.52M+$1.58M (+31.9%)

New holders (10)

Institutions that held Neuroone Medical Technologies Corp at the end of Q4 2021 but not at the end of Q3 2021.

Institutions new to NMTC in Q4 2021
InstitutionSharesValue% of portfolio
Stonepine Capital Management, LLC498,354$967.0K0.44%
AIGH Capital Management LLC475,000$921.0K0.29%
Bleichroeder LP375,000$728.0K0.11%
Vanguard Group Inc217,232$421.0K0.00%
Worth Venture Partners, LLC108,964$211.0K0.10%
Eidelman Virant Capital75,000$146.0K0.05%
Drive Wealth Management, LLC66,667$129.0K0.11%
Aristides Capital LLC36,800$71.0K0.04%
Northern Trust Corp15,376$30.0K0.00%
FMR LLC43$00.00%

Sold out (2)

Institutions that held Neuroone Medical Technologies Corp at the end of Q3 2021 and filed for Q4 2021 without it.

Institutions that sold out of NMTC in Q4 2021
InstitutionShares, Q3 2021Value, Q3 2021
Premier Asset Management LLC50,000$197.0K
Meridian Wealth Partners, LLC200$1.00K